RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 77.10
-0.35 (-0.45%)
Aug 15, 2025, 4:08 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 45.26 billion as of August 15, 2025. Its market cap has increased by 262.31% in one year.
Market Cap
45.26B
Enterprise Value
47.41B
Revenue
2.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
77.10
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 45.26B, an increase of 35.56%. That is a compound annual growth rate of 6.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 45.32B | 223.59% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | 46.53B | 39.37% |
| Nov 9, 2020 | 33.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 266.94B |
| Hansoh Pharmaceutical Group Company | 223.44B |
| JD Health International | 175.53B |
| Innovent Biologics | 164.42B |
| Akeso | 147.38B |
| Sino Biopharmaceutical | 136.28B |
| WuXi Biologics | 125.45B |
| CSPC Pharmaceutical Group | 119.48B |